A carregar...
Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
BACKGROUND: Low-molecular-weight heparin (LMWH) is the standard treatment for venous thromboembolism (VTE) in patients with active cancer. However, use of factor Xa inhibitors, such as rivaroxaban, is increasing on the basis of limited clinical evidence. The present single-center study compared the...
Na minha lista:
| Publicado no: | J Korean Med Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Academy of Medical Sciences
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543062/ https://ncbi.nlm.nih.gov/pubmed/31144482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e160 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|